COVID-19 Impact on Global Polymyositis Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 99 pages | ID: C5C7C53B8E6BEN
QYResearch

Abstracts

This report focuses on the global Polymyositis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Polymyositis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Hospira, Inc.
• Antares Pharma, Inc.
• Medexus Pharma, Inc.
• Fresenius SE & Co. KGaA
• Mylan N.V.
• Alcami Corporation
• Teva Pharmaceuticals
• Novartis AG
• Genentech, Inc.

Market segment by Type, the product can be split into

• Immunosuppressant
• Alkylating Agent
• Immunoglobulin
• Monoclonal Antibodies
• Corticosteroids

Market segment by Application, split into

• Hospitals
• Clinic
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Polymyositis Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Polymyositis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Polymyositis Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Polymyositis Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Polymyositis Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Immunosuppressant
  1.4.3 Alkylating Agent
  1.4.4 Immunoglobulin
  1.4.5 Monoclonal Antibodies
  1.4.6 Corticosteroids
1.5 Market by Application
  1.5.1 Global Polymyositis Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinic
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Polymyositis Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Polymyositis Treatment Industry
    1.6.1.1 Polymyositis Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Polymyositis Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Polymyositis Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Polymyositis Treatment Market Perspective (2015-2026)
2.2 Polymyositis Treatment Growth Trends by Regions
  2.2.1 Polymyositis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Polymyositis Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Polymyositis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Polymyositis Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Polymyositis Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Polymyositis Treatment Players by Market Size
  3.1.1 Global Top Polymyositis Treatment Players by Revenue (2015-2020)
  3.1.2 Global Polymyositis Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Polymyositis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Polymyositis Treatment Market Concentration Ratio
  3.2.1 Global Polymyositis Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Polymyositis Treatment Revenue in 2019
3.3 Polymyositis Treatment Key Players Head office and Area Served
3.4 Key Players Polymyositis Treatment Product Solution and Service
3.5 Date of Enter into Polymyositis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Polymyositis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Polymyositis Treatment Forecasted Market Size by Type (2021-2026)

5 POLYMYOSITIS TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Polymyositis Treatment Market Size by Application (2015-2020)
5.2 Global Polymyositis Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Polymyositis Treatment Market Size (2015-2020)
6.2 Polymyositis Treatment Key Players in North America (2019-2020)
6.3 North America Polymyositis Treatment Market Size by Type (2015-2020)
6.4 North America Polymyositis Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Polymyositis Treatment Market Size (2015-2020)
7.2 Polymyositis Treatment Key Players in Europe (2019-2020)
7.3 Europe Polymyositis Treatment Market Size by Type (2015-2020)
7.4 Europe Polymyositis Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Polymyositis Treatment Market Size (2015-2020)
8.2 Polymyositis Treatment Key Players in China (2019-2020)
8.3 China Polymyositis Treatment Market Size by Type (2015-2020)
8.4 China Polymyositis Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Polymyositis Treatment Market Size (2015-2020)
9.2 Polymyositis Treatment Key Players in Japan (2019-2020)
9.3 Japan Polymyositis Treatment Market Size by Type (2015-2020)
9.4 Japan Polymyositis Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Polymyositis Treatment Market Size (2015-2020)
10.2 Polymyositis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Polymyositis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Polymyositis Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Polymyositis Treatment Market Size (2015-2020)
11.2 Polymyositis Treatment Key Players in India (2019-2020)
11.3 India Polymyositis Treatment Market Size by Type (2015-2020)
11.4 India Polymyositis Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Polymyositis Treatment Market Size (2015-2020)
12.2 Polymyositis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Polymyositis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Polymyositis Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Hospira, Inc.
  13.1.1 Hospira, Inc. Company Details
  13.1.2 Hospira, Inc. Business Overview and Its Total Revenue
  13.1.3 Hospira, Inc. Polymyositis Treatment Introduction
  13.1.4 Hospira, Inc. Revenue in Polymyositis Treatment Business (2015-2020))
  13.1.5 Hospira, Inc. Recent Development
13.2 Antares Pharma, Inc.
  13.2.1 Antares Pharma, Inc. Company Details
  13.2.2 Antares Pharma, Inc. Business Overview and Its Total Revenue
  13.2.3 Antares Pharma, Inc. Polymyositis Treatment Introduction
  13.2.4 Antares Pharma, Inc. Revenue in Polymyositis Treatment Business (2015-2020)
  13.2.5 Antares Pharma, Inc. Recent Development
13.3 Medexus Pharma, Inc.
  13.3.1 Medexus Pharma, Inc. Company Details
  13.3.2 Medexus Pharma, Inc. Business Overview and Its Total Revenue
  13.3.3 Medexus Pharma, Inc. Polymyositis Treatment Introduction
  13.3.4 Medexus Pharma, Inc. Revenue in Polymyositis Treatment Business (2015-2020)
  13.3.5 Medexus Pharma, Inc. Recent Development
13.4 Fresenius SE & Co. KGaA
  13.4.1 Fresenius SE & Co. KGaA Company Details
  13.4.2 Fresenius SE & Co. KGaA Business Overview and Its Total Revenue
  13.4.3 Fresenius SE & Co. KGaA Polymyositis Treatment Introduction
  13.4.4 Fresenius SE & Co. KGaA Revenue in Polymyositis Treatment Business (2015-2020)
  13.4.5 Fresenius SE & Co. KGaA Recent Development
13.5 Mylan N.V.
  13.5.1 Mylan N.V. Company Details
  13.5.2 Mylan N.V. Business Overview and Its Total Revenue
  13.5.3 Mylan N.V. Polymyositis Treatment Introduction
  13.5.4 Mylan N.V. Revenue in Polymyositis Treatment Business (2015-2020)
  13.5.5 Mylan N.V. Recent Development
13.6 Alcami Corporation
  13.6.1 Alcami Corporation Company Details
  13.6.2 Alcami Corporation Business Overview and Its Total Revenue
  13.6.3 Alcami Corporation Polymyositis Treatment Introduction
  13.6.4 Alcami Corporation Revenue in Polymyositis Treatment Business (2015-2020)
  13.6.5 Alcami Corporation Recent Development
13.7 Teva Pharmaceuticals
  13.7.1 Teva Pharmaceuticals Company Details
  13.7.2 Teva Pharmaceuticals Business Overview and Its Total Revenue
  13.7.3 Teva Pharmaceuticals Polymyositis Treatment Introduction
  13.7.4 Teva Pharmaceuticals Revenue in Polymyositis Treatment Business (2015-2020)
  13.7.5 Teva Pharmaceuticals Recent Development
13.8 Novartis AG
  13.8.1 Novartis AG Company Details
  13.8.2 Novartis AG Business Overview and Its Total Revenue
  13.8.3 Novartis AG Polymyositis Treatment Introduction
  13.8.4 Novartis AG Revenue in Polymyositis Treatment Business (2015-2020)
  13.8.5 Novartis AG Recent Development
13.9 Genentech, Inc.
  13.9.1 Genentech, Inc. Company Details
  13.9.2 Genentech, Inc. Business Overview and Its Total Revenue
  13.9.3 Genentech, Inc. Polymyositis Treatment Introduction
  13.9.4 Genentech, Inc. Revenue in Polymyositis Treatment Business (2015-2020)
  13.9.5 Genentech, Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Polymyositis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Polymyositis Treatment Revenue
Table 3. Ranking of Global Top Polymyositis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Polymyositis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Immunosuppressant
Table 6. Key Players of Alkylating Agent
Table 7. Key Players of Immunoglobulin
Table 8. Key Players of Monoclonal Antibodies
Table 9. Key Players of Corticosteroids
Table 10. COVID-19 Impact Global Market: (Four Polymyositis Treatment Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Polymyositis Treatment Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Polymyositis Treatment Players to Combat Covid-19 Impact
Table 15. Global Polymyositis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Polymyositis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Polymyositis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Polymyositis Treatment Market Share by Regions (2015-2020)
Table 19. Global Polymyositis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Polymyositis Treatment Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Polymyositis Treatment Market Growth Strategy
Table 25. Main Points Interviewed from Key Polymyositis Treatment Players
Table 26. Global Polymyositis Treatment Revenue by Players (2015-2020) (Million US$)
Table 27. Global Polymyositis Treatment Market Share by Players (2015-2020)
Table 28. Global Top Polymyositis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polymyositis Treatment as of 2019)
Table 29. Global Polymyositis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Polymyositis Treatment Product Solution and Service
Table 32. Date of Enter into Polymyositis Treatment Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Polymyositis Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. Global Polymyositis Treatment Market Size Share by Type (2015-2020)
Table 36. Global Polymyositis Treatment Revenue Market Share by Type (2021-2026)
Table 37. Global Polymyositis Treatment Market Size Share by Application (2015-2020)
Table 38. Global Polymyositis Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. Global Polymyositis Treatment Market Size Share by Application (2021-2026)
Table 40. North America Key Players Polymyositis Treatment Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Polymyositis Treatment Market Share (2019-2020)
Table 42. North America Polymyositis Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. North America Polymyositis Treatment Market Share by Type (2015-2020)
Table 44. North America Polymyositis Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. North America Polymyositis Treatment Market Share by Application (2015-2020)
Table 46. Europe Key Players Polymyositis Treatment Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Polymyositis Treatment Market Share (2019-2020)
Table 48. Europe Polymyositis Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Polymyositis Treatment Market Share by Type (2015-2020)
Table 50. Europe Polymyositis Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Polymyositis Treatment Market Share by Application (2015-2020)
Table 52. China Key Players Polymyositis Treatment Revenue (2019-2020) (Million US$)
Table 53. China Key Players Polymyositis Treatment Market Share (2019-2020)
Table 54. China Polymyositis Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. China Polymyositis Treatment Market Share by Type (2015-2020)
Table 56. China Polymyositis Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. China Polymyositis Treatment Market Share by Application (2015-2020)
Table 58. Japan Key Players Polymyositis Treatment Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Polymyositis Treatment Market Share (2019-2020)
Table 60. Japan Polymyositis Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Polymyositis Treatment Market Share by Type (2015-2020)
Table 62. Japan Polymyositis Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Polymyositis Treatment Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Polymyositis Treatment Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Polymyositis Treatment Market Share (2019-2020)
Table 66. Southeast Asia Polymyositis Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Polymyositis Treatment Market Share by Type (2015-2020)
Table 68. Southeast Asia Polymyositis Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Polymyositis Treatment Market Share by Application (2015-2020)
Table 70. India Key Players Polymyositis Treatment Revenue (2019-2020) (Million US$)
Table 71. India Key Players Polymyositis Treatment Market Share (2019-2020)
Table 72. India Polymyositis Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. India Polymyositis Treatment Market Share by Type (2015-2020)
Table 74. India Polymyositis Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. India Polymyositis Treatment Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Polymyositis Treatment Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Polymyositis Treatment Market Share (2019-2020)
Table 78. Central & South America Polymyositis Treatment Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Polymyositis Treatment Market Share by Type (2015-2020)
Table 80. Central & South America Polymyositis Treatment Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Polymyositis Treatment Market Share by Application (2015-2020)
Table 82. Hospira, Inc. Company Details
Table 83. Hospira, Inc. Business Overview
Table 84. Hospira, Inc. Product
Table 85. Hospira, Inc. Revenue in Polymyositis Treatment Business (2015-2020) (Million US$)
Table 86. Hospira, Inc. Recent Development
Table 87. Antares Pharma, Inc. Company Details
Table 88. Antares Pharma, Inc. Business Overview
Table 89. Antares Pharma, Inc. Product
Table 90. Antares Pharma, Inc. Revenue in Polymyositis Treatment Business (2015-2020) (Million US$)
Table 91. Antares Pharma, Inc. Recent Development
Table 92. Medexus Pharma, Inc. Company Details
Table 93. Medexus Pharma, Inc. Business Overview
Table 94. Medexus Pharma, Inc. Product
Table 95. Medexus Pharma, Inc. Revenue in Polymyositis Treatment Business (2015-2020) (Million US$)
Table 96. Medexus Pharma, Inc. Recent Development
Table 97. Fresenius SE & Co. KGaA Company Details
Table 98. Fresenius SE & Co. KGaA Business Overview
Table 99. Fresenius SE & Co. KGaA Product
Table 100. Fresenius SE & Co. KGaA Revenue in Polymyositis Treatment Business (2015-2020) (Million US$)
Table 101. Fresenius SE & Co. KGaA Recent Development
Table 102. Mylan N.V. Company Details
Table 103. Mylan N.V. Business Overview
Table 104. Mylan N.V. Product
Table 105. Mylan N.V. Revenue in Polymyositis Treatment Business (2015-2020) (Million US$)
Table 106. Mylan N.V. Recent Development
Table 107. Alcami Corporation Company Details
Table 108. Alcami Corporation Business Overview
Table 109. Alcami Corporation Product
Table 110. Alcami Corporation Revenue in Polymyositis Treatment Business (2015-2020) (Million US$)
Table 111. Alcami Corporation Recent Development
Table 112. Teva Pharmaceuticals Company Details
Table 113. Teva Pharmaceuticals Business Overview
Table 114. Teva Pharmaceuticals Product
Table 115. Teva Pharmaceuticals Revenue in Polymyositis Treatment Business (2015-2020) (Million US$)
Table 116. Teva Pharmaceuticals Recent Development
Table 117. Novartis AG Business Overview
Table 118. Novartis AG Product
Table 119. Novartis AG Company Details
Table 120. Novartis AG Revenue in Polymyositis Treatment Business (2015-2020) (Million US$)
Table 121. Novartis AG Recent Development
Table 122. Genentech, Inc. Company Details
Table 123. Genentech, Inc. Business Overview
Table 124. Genentech, Inc. Product
Table 125. Genentech, Inc. Revenue in Polymyositis Treatment Business (2015-2020) (Million US$)
Table 126. Genentech, Inc. Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Polymyositis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Immunosuppressant Features
Figure 3. Alkylating Agent Features
Figure 4. Immunoglobulin Features
Figure 5. Monoclonal Antibodies Features
Figure 6. Corticosteroids Features
Figure 7. Global Polymyositis Treatment Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Polymyositis Treatment Report Years Considered
Figure 12. Global Polymyositis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Polymyositis Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Polymyositis Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Polymyositis Treatment Market Share by Players in 2019
Figure 17. Global Top Polymyositis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polymyositis Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Polymyositis Treatment Revenue in 2019
Figure 19. North America Polymyositis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Polymyositis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Polymyositis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Polymyositis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Polymyositis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Polymyositis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Polymyositis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Hospira, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Hospira, Inc. Revenue Growth Rate in Polymyositis Treatment Business (2015-2020)
Figure 28. Antares Pharma, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Antares Pharma, Inc. Revenue Growth Rate in Polymyositis Treatment Business (2015-2020)
Figure 30. Medexus Pharma, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Medexus Pharma, Inc. Revenue Growth Rate in Polymyositis Treatment Business (2015-2020)
Figure 32. Fresenius SE & Co. KGaA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Fresenius SE & Co. KGaA Revenue Growth Rate in Polymyositis Treatment Business (2015-2020)
Figure 34. Mylan N.V. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Mylan N.V. Revenue Growth Rate in Polymyositis Treatment Business (2015-2020)
Figure 36. Alcami Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Alcami Corporation Revenue Growth Rate in Polymyositis Treatment Business (2015-2020)
Figure 38. Teva Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Teva Pharmaceuticals Revenue Growth Rate in Polymyositis Treatment Business (2015-2020)
Figure 40. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Novartis AG Revenue Growth Rate in Polymyositis Treatment Business (2015-2020)
Figure 42. Genentech, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Genentech, Inc. Revenue Growth Rate in Polymyositis Treatment Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed